Dermata Therapeutics Inc (DRMA)


Stock Price Forecast

March 27, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Dermata Therapeutics Inc chart...

About the Company

dermata therapeutics, llc is a research company based out of 12340 el camino real, san diego, california, united states.

Exchange

NASDAQ

$M

Total Revenue

6

Employees

$2M

Market Capitalization

-0.16

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $DRMA News

Dermata Therapeutics Provides Corporate Update and Reports Full Year 2023 Financial Results

7d ago, source:

Initiated enrollment of DMT310 Phase 3 Spongilla Treatment of Acne Research (STAR-1) clinical trial in Q4 2023 - - Raised ...

Larimar Therapeutics Reports Fourth Quarter and Full Year 2023 Operating and Financial Results and Provides Update on Nomlabofusp Development

14d ago, source:

Positive top-line data from Phase 2 dose exploration study of nomlabofusp, which was generally well-tolerated, with dose-dependent increases in ...

Larimar Therapeutics to Present at Global Biopharma Conference in Miami

17d ago, source: MyChesCo on MSN

Larimar Therapeutics, Inc. (Nasdaq: LRMR), a biotechnology company specializing in the development of gene therapies, ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...